Energy dependent transport of xenobiotics and its relevance to multidrug resistance

Current Cancer Drug Targets

Volumn 3, Issue 2, 2003, Pages 89-107

  Sharma, Rajendra ^a,c   Awasthi, Yogesh C ^a   Yang, Yusong ^a   Sharma, Abha ^a   Singhal, Sharad S ^b   Awasthi, Sanjay ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN;

BIOTRANSFORMATION; CANCER CELL; CATALYSIS; CELL DEATH; CONFORMATIONAL TRANSITION; DETOXIFICATION; ENERGY TRANSFER; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHILICITY; LIPID BILAYER; MEMBRANE BINDING; MULTIDRUG RESISTANCE; PROTEIN TRANSPORT; REVIEW; TRANSPORT KINETICS; XENOBIOTIC METABOLISM;

ANIMALS; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; ENERGY METABOLISM; HUMANS; XENOBIOTICS;

EID: 0037380688     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009033482047     Document Type: Review

References (158)

1. nd Edition; John Wiley & Sons: New York, 1959.
2. Raucey, J. L.; Allen, S. W. Recent Advances in P450 Research, Pharmacogenomics J. 2001, 1, 178-186.
3. Mannervik, B.; Danielson, U. H. Glutathione S-Transferases Structure and Catalytic Activity. CRC Crit. Rev. Biochem. 1988, 23, 283-337.
4. Hayes, J. D.; Pulford, D. J. The Glutathione S-Transferase Supergene Family: Regulation of GST and Contribution of the Enzymes to Cancer Prevention and Drug Resistance. Crit. Rev. Biochem. Mol. Biol. 1995, 30, 445-600.
5. Mulder, G. J. Glucuronidation and its Role in Regulation of Biological Activity of Drugs. Ann. Rev. Pharmacol. Toxicol. 1992, 32, 25-49.
6. Awasthi, Y. C.; Sharma, R.; Singhal, S. S. Human Glutathione S-Transferases. Int. J. Biochem. 1994, 26, 295-308.
7. Ishikawa, T.; Akimuru, K. Transport of Glutathione S- Conjugates from Cancer Cells: Function and Structure of GS-X Pump. In: Glutathione S-Transferases Structure Function and Clinical Implications; Vermeulen, N.; Pe Mulder, G.J.; Nieuwenhuyse, H.; Peters, W. H. M.; Vanbladereen, P. J. Eds.; Taylor & Francis: London, 1996, pp. 199-211.
8. Zimniak, P.; Awasthi, Y. C. ATP-Dependent Transport Systems for Organic Anions. Hepatology 1993, 17, 330-339.
9. Ueda, K.; Masuo, M.; Tanabe, K.; Morito, K.; Kioka, N.; Amachi, T. Comparative Aspects of the Function and Mechanism of SUR1 and MDR1 Proteins. Blochim. Biophys. Acta 1999, 1461, 305-313.
10. Saier, M. H. Jr.; Paulsen, I. T. Phylogeny of Multidrug Transporters. Sem. Cell. Dev. Biol. 2001, 12, 205-213.
11. Zastrow, M.; Mostov, K. A New Thread in an Intricate Web. Science 2001, 294, 1845-1847.
12. Zimniak, P.; Pikula, S.; Bandorowicz-Pikula, J.; Awasthi, Y. C. Mechanisms for Xenobiotic Transport in Biological Membranes. Toxicol. Lett. 1999, 106, 107-118.
13. Tew, K. D. Glutathione-Associated Enzymes in Anticancer Drug Resistance. Cancer. Res. 1994, 54, 4313-4320.
14. Gottesman, M. M.; Pastan, I. Biochemistry of Multidrug Resistance Mediated by the Multidrug Transporter. Annu. Rev. Biochem. 1993, 62, 385-427.
15. Adams, J. M.; Cory, S. The Bcl-2 Protein Family: Arbiters of Cell Survival. Science 1998, 281, 1322-1326.
16. O'connor, P. M.; Jackman, J.; Bae, I.; Myers, T. G.; Fan, S.; Mutoh, M.; Scudiero, D. A.; Monks, A; Sausville, E. A.; Weinstein, J. N.; Friend, S.; Fornace, A. J. Jr.; Kohn, K. W. Characterization of the p53 Tumor Suppressor Pathway in Cell Lines of the National Cancer Institute Anticancer Drug Screen and Correlations With the Growth-Inhibitory Potency of 123 Anticancer Agents. Cancer Res. 1997, 57, 4285-4300.
17. Stavrovskaya, A. A. Cellular Mechanisms of Multidrug Resistance of Tumor Cells Biochemistry (Moscow) 2000, 65, 95-106.
18. Van Bambeke, F.; Balzi, E.; Tulkens, P. M. Antibiotic Efflux Pumps Biochem. Pharmacol. 2000, 60, 457-470.
19. Holland, B.; Blight, M. A. ABC-ATPases, Adaptable Energy Generators Fuelling Transmembrane Movement of A Variety of Molecules in Organisms from Bacteria to Humans. J. Mol. Biol. 1999, 293, 381-399.
20. Higgins, C. F. ABC Transporters: from Microorganisms to Man. Annu. Rev. Cell Biol. 1992, 8, 67-113.
21. Saier, M. H. Jr.; Paulsen, I. T.; Sliwinski, M. K.; Pao, S. S.; Skurray, R. A.; Nikaido, H. Evolutionary Origins of Multidrug and Drug-Specific Efflux Pumps in Bacteria. FASEB J. 1998, 12, 265-274.
22. Borst, P.; Zelcer, N.; Van Helvoort, A. ABC Transporters in Lipid Transport Biochim. Biophys. Acta 2000, 1486, 28-44.
23. Kipp, H.; Arias, I. M. Trafficking of Canalicular ABC Transporters in Hepatocytes Annu. Rev. Physiol. 2002, 64, 595-608.
24. Leslie, E. M.; Deeley, R. G.; Cole, S. P. Toxicological Relevance of the Multidrug Resistance Protein 1, MRP1 (ABC c1) and Related Transporters. Toxicology 2001, 1673-1683.
25. Higgins, C. F.; Linton, K. J. the XYZ of ABC Transporters. Science 2001, 293, 1782-1784.
26. Shapiro, A. B.; Ling, V. ATPase Activity of Purified and Reconstituted P-Glycoprotein from Chinese Hamster Ovary Cells. J. Biol. Chem. 1994, 269, 3745-3754.
27. Shapiro, A. B.; Ling, V. Reconstitution of Drug Transport by Purified P-Glycoprotein. J. Biol. Chem. 1995, 270, 16167-16175.
28. Ambudkar, S. V. Purification and Reconstitution of Functional Human P-Glycoprotein. J. Bioenerg. Biomembr. 1995, 27, 23-29.
29. Dean, M.; Hamon, Y.; Chimini, G. the Human ATP-Binding Cassette (ABC) Transporter Superfamily. J. Lipid. Res. 2001, 42, 1007-1017.
30. Smit, J. J.; Schinkel, A. H.; Oude Elferink, R. P.; Groen, A. K.; Wagenaar, E.; Van Deemter, L.; Mol, C. A.; Ottenhoff, R.; Van Der Lugt, N. M.; Van Roon, M. A.; van der valk, M. A.; Offerhaus, G. J. A.; Berns, A. J. M.; Borst, P. Homozygous Disruption of the Murine MDR2 PGlycoprotein Gene Leads to a Complete Absence of Phospholipid from Bile and to Liver Disease. Cell 1993, 75, 451-462.
31. Higgins, C. F.; Gottesman, M. M. Is the Multidrug Transporter a Flippase? Trends Biochem. Sci. 1992, 17, 18-21.
32. Johnstone, R. W.; Ruefil, A. A.; Smyth, M. J. Multiple Physiological Functions for Multidrug Transporter P-Glycoprotein? Trends Biochem. Sci. 2000, 25, 1-6.
33. Abraham, E. H.; Shrivastav, B.; Salikhova, A. Y.; Sterling, K. M; Johnston, N.; Guidotti, G.; Scala, S.; Litman, T.; Chan, K. C.; Arceci, R. J.; Steiglitz, K.; Herscher, L.; Okunieff, P. Cellular and Biophysical Evidence for Interactions Between Adenosine Triphosphate and P-Glycoprotein Substrates: Functional Implications for Adenosine Triphosphate/Drug Cotransport in P-Glycoprotein Over Expressing Tumor Cells and in PGlycoprotein Low-Level Expressing Erythrocytes. Blood. Cells. Mol. Dis. 2001, 27, 181-200.
34. Zheleznova, E. E.; Markham, P.; Edgar, R.; Bibi, E.; Neyfakh, A. A.; Brennan, R. G. A Structure-Based Mechanism for Drug Binding by Multidrug Transporters Trends Biochem. Sci. 2000, 25, 39-43.
35. Van Veen, H. W.; Margolles, A.; Muller, M.; Higgins, C. F.; Konings, W. N. The Homodimeric ATP-Binding Cassette Transporter LMRA Mediates Multidrug Transport by an Alternating Two-Site (Two-Cylinder Engine) Mechanism. EMBO J. 2000, 19, 2503-2514.
36. Chang, G.; Roth, C. B. Structure of MSBA from E. coli: a Homolog of the Multidrug Resistance ATP Binding Cassette (ABC) Transporters. Science 2001, 293, 1793-1800.
37. Thiebaut, F.; Tsuruo, T.; Hamada, H.; Gottesman, M. M.; Pastan, I.; Willingham M. C. Cellular Localization of the Multidrug-Resistance Gene Product P-Glycoprotein in Normal Human Tissues. Proc. Natl. Acad. Sci. USA 1987, 84, 7735-7738.
38. Ambudkar, S. V.; Dey, S.; Hrycyna, C. A.; Ramachandra, M.; Pastan, I.; Gottesman, M. M. Biochemical, Cellular, and Pharmacological Aspects of the Multidrug Transporter. Annu. Rev. Pharm. Toxicol. 1999, 39, 361-398.
39. Meister, A. Glutathione Deficiency Produced by Inhibition of its Synthesis, and its Reversal; Applications in Research and therapy. Pharmacol. Ther. 1991, 51, 155-94.
40. Meister, A. Glutathione, Ascorbate, and Cellular Protection. Cancer Res. 1994, 54, 1969s-1975s.
41. O'brien, M. L.; Tew, K. D. Glutathione and Related Enzymes in Multidrug Resistance. Eur. J. Cancer. 1996, 32a, 967-978.
42. Gaudiano, G.; Koch, T. H.; Lo Bello, M.; Nuccetelli, M.; Ravagnan, G.; Serafino, A.; Sinibaldi-Vallebona, P. Lack of Glutathione Conjugation to Adriamycin in Human Breast Cancer MCF-7/Dox Cells. Inhibition of Glutathione S-Transferase P1-1 by Glutathione Conjugates from Anthracyclines. Biochem. Pharmacol. 2000, 60, 1915-1923.
43. Calvert, P.; Yao, K. S.; Hamilton, T. C.; O'dwyer, P. J. Clinical Studies of Reversal of Drug Resistance Based On Glutathione. Chem. Biol. Interact. 1998, 111-112, 213-24.
44. Simsek, T.; Ozbilim, G.; Gulkesen, H; Kaya, H.; Sargin, F.; Karaveli, S. Drug Resistance in Epithelial Ovarian Cancer: P-Glycoprotein and Glutathion S-Transferase. Can they Play an Important Role in Detecting Response to Platinum-Based Chemotherapy As A First-Line therapy. Eur. J. Gynaecol. Oncol. 2001, 22, 436-438.
45. Harbottle, A.; Daly, A. K.; Atherton, K. Campbell, F. C. Role of Glutathione S-Transferase P1, P-Glycoprotein and Multidrug Resistance-Associated Protein 1 in Acquired Doxorubicin Resistance. Int. J. Cancer 2001, 92, 777-783.
46. Medh, R. D.; Gupta, V.; Zhang, Y.; Awasthi, Y. C.; Belli, J. A. Glutathione S-Transferase and P-Glycoprotein in Multidrug Resistant Chinese Hamster Cells. Biochem. Pharmacol. 1990, 39, 1641-1645.
47. Batist, G.; Tulpule, A.; Sinha, B. K.; Katki, A. G.; Myers, C. E.; Cowan, K. H. Overexpression of a Novel Anionic Glutathione Transferase in Multidrug-Resistant Human Breast Cancer Cells. J Biol. Chem. 1986, 261, 15544-15549.
48. Moscow, J. A.; Townsend, A. J.; Cowan, K. H. Elevation of Pi Class Glutathione S-Transferase Activity in Human Breast Cancer Cells by Transfection of the GST Pi Gene and its Effect on Sensitivity to Toxins. Mol. Pharmacol. 1989, 36, 22-28.
49. Asakura, T.; Hashizume, Y.; Tashiro, K.; Searashi, Y.; Ohkawa, K.; Nishihira, J.; Sakai, M.; Shibasaki, T. Suppression of GST-P by Treatment with GlutathioneDoxorubicin Conjugate Induces Potent Apoptosis in Rat Hepatoma Cells. Int. J. Cancer 2001, 94, 171-177.
50. Sinha B. K.; Mimnaugh, E. G.; Rajagopalan, S.; Myers, C. E. Adriamycin Activation and Oxygen Free Radical formation in Human Breast Tumor Cells: Protective Role of Glutathione Peroxidase in Adriamycin Resistance. Cancer Res. 1989, 49, 3844-3848.
51. Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. the Multidrug Resistance Protein Family. Biochim. Biophys. Acta 1999, 1461, 347-357.
52. Tammur, J.; Prades, C.; Arnould, I.; Rzhetsky, A.; Hutchinson, A.; Adachi, M.; Schuetz, J.; Swoboda, K.; Ptacek, L.; Rosier, M.; Dean, M.; Allikmets, R. Two New Genes from Human ATP-Binding Cassette Transporter Superfamily ABC c11 and ABC c12, Tandemly Duplicated on Chromosome 16q12. Genes 2001, 273, 89-96.
53. Adachi, M.; Reid, G.; Schuetz, J. D. therapeutic and Biological Importance of Getting Nucleotides out of Cells: a Case for the ABC Transporters, MRP4 and 5. Adv. Drug. Deliv. Rev. 2002, 54, 1333-42.
54. Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G. Overexpression of a Transporter Gene in a Multidrug Resistant Human Lung Cancer Cell Line. Science 1992, 258, 1650-1654.
55. Mao, Q.; Deeley, R. G.; Cole, S. P. Functional Reconstitution of Substrate Transport by Purified Multidrug Resistance Protein MRP1 (ABC c1) in Phospholipid Vesicles. J. Biol. Chem. 2000, 275, 34166-34172.
56. Leier, I.; Jedlitschky, G.; Buchholz, U.; Cole, S. P.; Deeley, R. G.; Keppler, D. The MRP Gene Encodes an ATP-Dependent Export Pump for Leukotriene C4 and Structurally Related Conjugates. J Biol. Chem. 1994, 269, 27807-27810.
57. Loe, D. W.; Almquist, K. C.; Deeley, R. G.; Cole, S. P. Multidrug Resistance Protein (MRP)-Mediated Transport of Leukotriene C4 and Chemotherapeutic Agents in Membrane Vesicles. Demonstration of Glutathione-Dependent Vincristine Transport. J. Biol. Chem. 1996, 271, 9675-9682.
58. Paulusma, C. C.; Bosma, P. J.; Zaman, G. J.; Bakker, C. T.; Otter, M.; Scheffer, G. L.; Scheper, R. J.; Borst, P.; Oude Elferink, R. P. Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene. Science 1996, 271, 1126-1128.
59. Mcaleer, M. A.; Breen, M. A.; White, N. L.; Matthews, N. PABC11 (Also Known as MOAT-C and MRP5), A Member of the ABC Family of Proteins, Has Anion Transporter Activity but does not Confer Multidrug Resistance When Over Expressed in Human Embryonic Kidney 293 Cells. J. Biol. Chem. 1999, 274, 23541-23548.
60. Wijnholds, J.; Mol, C.A.; Van Deemter, L.; De Haas, M.; Scheffer, G.L.; Baas, F.; Beijnen, J.H.; Scheper, R.J.; Hatse, S.; De Clercq, E.; Balzarini, J.; Borst, P. Multidrug-Resistance Protein 5 is a Multispecific Organic Anion Transporter Able to Transport Nucleotide Analogs. Proc. Natl. Acad. Sci. USA 2000, 97, 7476-7481.
61. Renes, J.; De Vries, E. G.; Jansen, P. L.; Muller, M. The (Patho) Physiological Functions of the MRP Family. Drug Resist. Updat. 2000, 3, 289-302.
62. Jedlitschky, G.; Leier, I.; Buchholz, U.; Barnouin, K.; Kurz, G.; Keppler, D. Transport of Glutathione, Glucuronate, and Sulfate Conjugates by the MRP Gene-Encoded Conjugate Export Pump. Cancer Res. 1996, 56, 988-994.
63. Renes, J.; De Vries, E. G.; Nienhuis, E. F.; Jansen, P. L.; Muller, M. ATP- and Glutathione-Dependent Transport of Chemotherapeutic Drugs by the Multidrug Resistance Protein MRP1. Br. J. Pharmacol. 1999, 126, 681-688.
64. Loe, D. W.; Deeley, R. G.; Cole, S. P. Characterization of Vincristine Transport by the M(R) 190,000 Multidrug Resistance Protein (MRP): Evidence for Co Transport with Reduced Glutathione. Cancer Res. 1998, 58, 5130-5135.
65. Flens, M. J.; Zaman, G. J.; Van Der Valk, P.; Izquierdo, M. A.; Schroeijers, A. B.; Scheffer, G. L.; Van Der Groep, P.; De Haas, M.; Meijer, C. J.; Scheper, R. J. Tissue Distribution of the Multidrug Resistance Protein. Am. J. Pathol. 1996, 148, 1237-1247.
66. Kool, M.; De Haas, M.; Scheffer, G. L.; Scheper, R. J.; Van Eijk, M. J.; Juijn, J. A.; Baas, F.; Borst, P. Analysis of Expression of CMOAT (MRP2), MRP3, MRP4, and MRP5, Homologues of the Multidrug Resistance-Associated Protein Gene (MRP1), in Human Cancer Cell Lines. Cancer Res. 1997, 57, 3537-3547.
67. Barrand, M. A.; Robertson, K. J.; Neo, S. Y.; Rhodes, T.; Wright, K. A.; Twentyman, P. R.; Scheper, R. J. Localisation of the Multidrug Resistance-Associated Protein, MRP, in Resistant Large-Cell Lung Tumour Cells. Biochem. Pharmacol. 1995, 50, 725-729.
68. Alvarez, M.; Robey, R.; Sandor, K.; Nishiyama, Y.; Matsumoto, K.; Paull, S.; Fojo, T. Using the National Cancer Institute Anti Cancer Drug Screen to Assess the Effect of MRP Expression on Drug Sensitivity Profiles. J. Pharmacol. Expt. Therapeut. 1998, 54, 802-814.
69. Ishikawa, T.; Ali-Osman, F. Glutathione-Associated Cis- Diamminedichloroplatinum (II) Metabolism and ATP-Dependent Efflux from Leukemia Cells. Molecular Characterization of Glutathione-Platinum Complex and its Biological Significance. J. Biol. Chem. 1993, 268, 20116-20125.
70. Ishikawa, T.; Bao, J.J.; Yamane, Y.; Akimaru, K.; Frindrich, K.; Wright, C.D.; Kuo, M. T. Coordinated Induction of MRP/GS-X Pump and Gamma-Glutamylcysteine Synthetase by Heavy Metals in Human Leukemia Cells. J. Biol. Chem. 1996, 271, 14981-14988.
71. Zaman, G. J. R.; Flens, M. J.; Van Leusden, M. R.; Dehaas, M.; Mulder, H. S.; Lankelma, J.; Pinedo, H. M.; Scheper, R. J.; Baas, F.; Broxterman, H. J.; Borst, P. the Human Multidrug Resistance-Associated Protein MRP is A Plasma Membrane Drug-Efflux Pump. Proc. Natl. Acad. Sci. USA 1994, 91, 8822-8826.
72. Broxterman, H. J.; Heijn, M.; Lankelma, J. How Does the MRP/Gs-X Pump Export Doxorubicin? J. Natl. Cancer. Inst. 1996, 88, 466-468.
73. Hollo, Z.; Homolya, L.; Davis, C. W.; Sarkadi, B. Calcein Accumulation As A Fluorometric Functional Assay of the Multidrug Transporter. Biochim. Biophys. Acta 1994 1191, 384-388.
74. Feller, N.; Broxterman, H. J.; Wahrer, D. C.; Pinedo, H. M. ATP-Dependent Efflux of Calcein by the Multidrug Resistance Protein (MRP): No Inhibition by Intracellular Glutathione Depletion. FEBS Lett. 1995, 368, 385-388.
75. Diah, S. K.; Smitherman, P. K.; Townsend, A. J.; Morrow, C. S. Detoxification of 1-Chloro-2,4-Dinitrobenzene in MCF7 Breast Cancer Cells Expressing Glutathione S-Transferase P1-1 and/or Multidrug Resistance Protein 1. Toxicol. Appl. Pharmacol. 1999, 157, 85-93.
76. Leier, I.; Jedlitschky, G.; Buchholz, U.; Center, M.; Cole, S. P.; Deeley, R. G.; Keppler, D. ATP-Dependent Glutathione Disulphide Transport Mediated by the MRP Gene-Encoded Conjugate Export Pump. Biochem. J. 1996, 314, 433-437.
77. He, N. G.; Singhal, S. S.; Srivastava, S. K.; Zimniak, P.; Awasthi, Y. C.; Awasthi, S. Transfection of a 4-Hydroxynonenal Metabolizing Glutathione S-Transferase Isozyme, Mouse GSTa4-4, Confers Doxorubicin Resistance to Chinese Hamster Ovary Cells. Arch. Biochem. Biophys. 1996, 333, 214-220.
78. Renes, J.; De Vries, E. E.; Hooiveld, G. J.; Krikken. I.; Jansen, P. L.; Muller, M. Multidrug Resistance Protein MRP1 Protects Against the Toxicity of the Major Lipid Peroxidation Product 4-Hydroxynonenal. Biochem. J. 2000, 350, 555-561.
79. Podgorski, I.; Bull, A.W. Energy-Dependent Export of the 13-Oxooctadecadienoic Acid-Glutathione Conjugate from Ht-29 Cells and Plasma Membrane Vesicles. Biochim. Biophys. Acta 2001, 1533, 55-65.
80. Evers, R.; Cnubben, N. H.; Wijnholds, J.; Van Deemter, L.; Van Bladeren, P. J.; Borst, P. Transport of Glutathione Prostaglandin a Conjugates by the Multidrug Resistance Protein 1. FEBS Lett. 1997, 419, 112-116.
81. Sharma, R.; Singhal, S. S.; Cheng, J.; Yang, Y.; Sharma, A.; Zimniak P.; Awasthi, S.; Awasthi, Y. C. RLIP76 is the Major ATP-Dependent Transporter of Glutathione-Conjugates and Doxorubicin in Human Erythrocytes. Arch. Biochem. Biophys. 2001, 391, 171-179.
82. Bates, S. E.; Robey, R.; Miyake, K.; Rao, K.; Ross, D. D.; Litman, T. The Role of Half-Transporters in Multidrug Resistance. J. Bioenerg. Biomembr. 2001, 33, 503-511.
83. Childs, S.; Yeh, R. L.; Georges, E.; Ling, V. Identification of a Sister Gene to P-Glycoprotein. Cancer. Res. 1995, 55, 2029-2034.
84. Doyle, L. A.; Yang, W.; Abruzzo, L. V.; Krogmann, T.; Gao, Y.; Rishi, A. K.; Ross, D. D. A Multidrug Resistance Transporter from Human Mcf-7 Breast Cancer Cells. Proc. Natl. Acad. Sci. USA 1998, 95, 15665-15670.
85. Lage, H.; Dietel, M. Effect of the Breast-Cancer Resistance Protein on Atypical Multidrug Resistance. Lancet. Oncol. 2000, 1, 169-175.
86. Litman, T.; Brangi, M.; Hudson, E.; Fetsch, P.; Abati, A.; Ross, D. D.; Miyake, K.; Resau, J. H.; Bates, S. E. The Multidrug-Resistant Phenotype Associated with Overexpression of the New ABC Half-Transporter, Mxr (ABC g2). J. CeIl. Sci. 2000, 113, 2011-2021.
87. Rocchi, E.; Khodjakov, A.; Volk, E. L.; Yang, C. H.; Litman, T.; Bates, S. E.; Schneider, E. The Product of the ABC Half-Transporter Gene ABC g2 (BCRP/MXR/ABC p) is Expressed in the Plasma Membrane. Biochem. Biophys. Res. Commun. 2000, 271, 42-46.
88. Van Den Heuvel-Eibrink, M. M.; Sonneveld, P.; Pieters, R. The Prognostic Significance of Membrane Transport-Associated Multidrug Resistance (MDR) Proteins in Leukemia. Int. J. Clin. Pharmacol. Ther. 2000, 38, 94-110.
89. Doyle, L. A.; Ross, D. D.; Sridhara, R.; Fojo, A. T.; Kaufmann, S. H.; Lee, E. J.; Schiffer, C. A. Expression of a 95 kDa Membrane Protein is Associated with Low Daunorubicin Accumulation in Leukaemic Blast Cells. Br. J. Cancer. 1995, 71, 52-58.
90. Ross, D. D.; Gao, Y.; Yang, W.; Leszy, J.; Shively, J. Doyle, L. A. The 95-Kilodalton Membrane Glycoprotein Over Expressed in Novel Multidrug-Resistant Breast Cancer Cells is NCA, the Nonspecific Cross-Reacting Antigen of Carcinoembryonic Antigen. Cancer. Res. 1997, 57, 5460-5464.
91. Kawaharata, H.; Hinoda, Y.; Itoh, F.; Endo, T.; Oikawa, S.; Nakazato, H.; Imai, K. Decreased Sensitivity of Carcinoembryonic Antigen cDNA-Transfected Cells to Adriamycin. Int. J. Cancer 1997, 72, 377-382.
92. Lee, J. S.; Scala, S.; Matsumoto, Y.; Dickstein, B.; Robey, R.; Zhan, Z.; Altenberg, G.; Bates, S. E. Reduced Drug Accumulation and Multidrug Resistance in Human Breast Cancer Cells Without Associated P-Glycoprotein or MRP Overexpression. J. CeIl. Biochem. 1997, 65, 513-526.
93. Lee, K.; Belinsky, M.G.; Bell, D. W.; Testa, J. R.; Kruh, G. D. Isolation of Moat-B, a Widely Expressed Multidrug Resistance-Associated Protein/Canalicular Multispecific Organic Anion Transporter-Related Transporter. Cancer. Res. 1998, 58, 2741-2747.
94. Martel, J.; Payet, M. D.; Dupuis, G. the MDR1 (P- Glycoprotein) and MRP (P-190) Transporters do not Play a Major Role in the Intrinsic Multiple Drug Resistance of Jurkat T Lymphocytes. Leuk. Res. 1997, 21, 1077-1086.
95. Scheffer, G. L.; Wijngaard, P. L.; Flens, M. J.; Izquierdo, M. A; Slovak, M. L.; Pinedo, H. M.; Meijer, C. J.; Clevers, H. C.; Scheper, R. J. The Drug Resistance-Related Protein Lrp is the Human Major Vault Protein. Nat. Med. 1995, 1, 578-582.
96. Carter, A.; Dann, E. J.; Katz, T.; Shechter, Y.; Oliven, A.; Regev, R.; Eytan, E.; Rowe, J. M.; Eytan, G. D. Cells from Chronic Myelogenous Leukaemia Patients At Presentation Exhibit Multidrug Resistance Not Mediated by Either MDR1 or MRP1. Br. J. Haematol. 2001, 114, 581-590.
97. Berger, W.; Elbling, L.; Micksche, M. Expression of the Major Vault Protein LRP in Human Non-Small-Cell Lung Cancer Cells: Activation by Short-Term Exposure to Antineoplastic Drugs. Int. J. Cancer 2000, 88, 293-300.
98. Schroeijers, A. B.; Scheffer, G. L.; Reurs, A. W.; Pijnenborg, A. C.; Abbondanza, C.; Wiemer, E. A.; Scheper, R. J. Detection of the Mr 110,000 Lung Resistance-Related Protein LRP/MVP with Monoclonal Antibodies. J. Histochem. Cytochem. 2001, 49, 1379- 1385.
99. Scheffer, G. L.; Schroeijers, A. B.; Izquierdo, M.; Wiemer, E. A.; Scheper, R. J. Lung Resistance-Related Protein/Major Vault Protein and Vaults in Multidrug-Resistant Cancer. Curr. Opin. Oncol. 2000, 12, 550-556.
100. Izquierdo, M.A.; Scheffer, G.L.; Flens, M.J.; Schroeijers, A.B.; Van Der Valk, P.; Scheper, R.J. Major Vault Protein Lrp-Related Multidrug Resistance. Eur. J. Cancer 1996, 32a, 979-984.
101. Chuman, Y.; Chen, Z. S.; Sumizawa. T.; Furukawa, T.; Haraguchi, M.; Takebayashi, Y.; Niwa, K.; Yamada, K.; Aikou, T.; Akiyama, S. Characterization of the ATP-Dependent Ltc4 Transporter in Cisplatin-Resistant Human Kb Cells. Biochem. Biophys. Res. Commun. 1996, 226, 158-165.
102. Sundkvist, E.; Jaeger, R.; Sager, G. Leukotriene C (4) (Ltc4) does not Share a Cellular Efflux Mechanism with cGMP: Characterization of cGMP Transport by Uptake to Inside-Out Vesicles from Human Erythrocytes. Biochim. Biophys. Acta 2000, 1463, 121-130.
103. Sharma, R.; Awasthi, S.; Zimniak, P.; Awasthi, Y. C. Transport of Glutathione-Conjugates In Human Erythrocytes Acta. Biochim. Pol. 2000, 47, 751-762.
104. Srivastava, S. K.; Beutler, E. The Transport of Oxidized Glutathione from Human Erythrocytes. J. Biol. Chem. 1969, 244, 9-16.
105. Awasthi, Y. C.; Garg, H. S.; Dao, D. D.; Partridge, C. A.; Srivastava, S. K. Enzymatic Conjugation of Erythrocyte Glutathione with 1-Chloro-2, 4-Dinitrobenzene: the Fate of Glutathione Conjugate in Erythrocytes and the Effect of Glutathione Depletion on Hemoglobin. Blood 1981, 58, 733-738.
106. LaBelle, E. F.; Singh, S.V.; Srivastava, S. K.; Awasthi, Y. C. Evidence for Different Transport Systems for Oxidized Glutathione and S-Dinitrophenyl Glutathione in Human Erythrocytes. Biochem. Biophys. Res. Commun. 1986, 139, 538-544.
107. LaBelle, E. F.; Singh, S. V.; Srivastava, S. K.; Awasthi, Y. C. Dinitrophenyl Glutathione Efflux from Human Erythrocytes is Primary Active ATP-Dependent Transport. Biochem. J. 1986, 238, 443-449.
108. Kondo, T.; Kawakami, Y.; Taniguchi, N.; Beutler, E. Glutathione Disulfide-Stimulated Mg2+-ATPase of Human Erythrocyte Membranes. Proc. Natl. Acad. Sci. USA 1987, 84, 7373-7377.
109. Sharma, R.; Gupta, S.; Ahmad, H.; Ansari, G. A. S.; Awasthi, Y. C. Stimulation of a Human Erythrocyte Membrane ATPase by Glutathione Conjugates Toxicol. Appl. Pharmacol. 1990, 104, 421-428.
110. Sharma, R.; Gupta, S.; Singh, S. V.; Medh, R. D.; Ahmad, H.; LaBelle, E. F.; Awasthi, Y. C. Purification and Characterization of Dinitrophenylglutathione ATPase of Human Erythrocytes and its Expression in other Tissues Biochem. Biophys. Res. Commun. 1990, 171, 155-161.
111. Awasthi, Y. C.; Singhal, S. S.; Gupta, S.; Ahmad, H.; Zimniak, P.; Radominska, A.; Lester, R.; Sharma, R. Purification and Characterization of an ATPase from Human Liver which Catalyzes ATP Hydrolysis in the Presence of the Conjugates of Bilirubin Bile Acids and Glutathione. Biochem. Biophys. Res. Commun. 1991, 175, 1090-1096.
112. Singhal, S. S.; Sharma, R.; Gupta, S.; Ahmad, H.; Zimniak, P.; Radominska, A.; Lester, R.; Awasthi, Y. C. The Anionic Conjugates of Bilirubin and Bile Acids Stimulate ATP Hydrolysis by S- (Dinitrophenyl) Glutathione ATPase of Human Erythrocyte. FEBS. Lett. 1991, 281, 255-7.
113. Saxena, M.; Singhal, S. S.; Awasthi, S.; Singh, S. V.; LaBelle, E. F.; Zimniak, P.; Awasthi, Y. C. Dinitrophenyl S-Glutathione ATPase Purified from Human Muscle Catalyzes ATP Hydrolysis in the Presence of Leukotrienes. Arch. Biochem. Biophys. 1992, 298, 231-237.
114. Kondo, T.; Miyamoto, K.; Gasa, S.; Taniguchi, N.; Kawakami, Y. Purification and Characterization of Glutathione Disulfide-Stimulated Mg2+-ATPase from Human Erythrocytes. Biochem. Biophys. Res. Commun. 1989, 162, 1-8.
115. Awasthi, S.; Singhal, S. S.; Srivastava, S. K.; Zimniak, P.; Bajpai, K. K.; Saxena, M.; Sharma, R.; Ziller, S. A. III; Frenkel, E. P.; Singh, S. V.; He, N. G.; Awasthi, Y. C. Adenosine Triphosphate-Dependent Transport of Doxorubicin, Daunomycin, and Vinblastine in Human Tissues by a Mechanism Distinct from the P-Glycoprotein. J. Clin. Invest. 1994, 93, 958-965.
116. Awasthi, S.; Singhal, S. S.; Srivastava, S. K.; Torman, R. T.; Zimniak, P.; Bandorowicz-Pikula, J.; Singh, S. V.; Piper, J. T.; Awasthi, Y. C.; Pikula, S. ATP-Dependent Human Erythrocyte Glutathione-Conjugate Transporter. I. Purification, Photoaffinity Labeling, and Kinetic Characteristics of ATPase Activity. Biochemistry 1998, 37, 5231-5238.
117. Awasthi, S.; Singhal, S. S.; Pikula, S.; Piper, J. T.; Srivastava, S. K.; Torman, R. T.; Bandorowicz-Pikula, J.; Lin, J. T.; Singh, S. V.; Zimniak, P.; Awasthi, Y. C. ATP-Dependent Human Erythrocyte Glutathione-Conjugate Transporter. II. Functional Reconstitution of Transport Activity. Biochemistry 1998, 37, 5239-5248.
118. Awasthi, S.; Singhal, S. S.; Pandya, U.; Gopal, S.; Zimniak, P.; Singh, S. V.; Awasthi, Y. C. ATP-Dependent Colchicine Transport by Human Erythrocyte Glutathione Conjugate Transporter. Toxicol. Appl. Pharmacol. 1999, 155, 215-226.
119. Zimniak, P.; Ziller, S. A. III; Panfil, I.; Radominska, A.; Wolters, H.; Kuipers, F.; Sharma, R.; Saxena, M.; Moslen, M. T.; Vore, M.; Vonk, R.; Awasthi, Y. C.; Lester, R. Identification of an Anion-Transport ATPase That Catalyzes Glutathione Conjugate-Dependent ATP Hydrolysis in Canalicular Plasma Membranes from Normal Rats and Rats with Conjugated Hyperbilirubinemia (Gy Mutant). Arch. Biochem. Biophys. 1992, 292, 534-538.
120. Pikula, S.; Hayden, J. B.; Awasthi, S.; Awasthi, Y. C.; Zimniak, P.; Organic Anion-Transporting ATPase of Rat Liver. Ii. Functional Reconstitution of Active Transport and Regulation by Phosphorylation. J. Biol. Chem. 1994, 269, 27574-27579.
121. Pikula, S.; Hayden, J. B.; Awasthi, S.; Awasthi, Y. C.; Zimniak, P. Organic Anion-Transporting ATPase of Rat Liver. I. Purification, Photoaffinity Labeling, and Regulation by Phosphorylation. J. Biol. Chem. 1994, 269, 27566-27573.
122. Jullien-Flores, V.; Dorseuil, O.; Romero, F.; Letourneur, F.; Saragosti, S.; Berger, R.; Tavitian, A.; Acon, G.; Camonis, J. H. Bridging Ral GTPase to Rho Pathways. RLIP76, a Ral Effector with Cdc42/Rac GTPase-Activating Protein Activity. J. Biol. Chem. 1995, 270, 22473-22477.
123. Ridley, A.J. Rho Family Proteins: Coordinating Cell Responses. Trends Cell. Biol. 2001, 11, 471-477.
124. Cantor, S. B.; Urano, T.; Feig, L.A. Identification and Characterization of Ral-Binding Protein 1, a Potential Downstream Target of Ral GTPases. Mol. Cell. Biol. 1995, 15, 4578-4584.
125. Park, S. H.; Weinberg, R. A. A Putative Effector of Ral Has Homology to Rho/Rac Gtpase Activating Proteins. Oncogene 1995, 11, 2349-2355.
126. Awasthi, S.; Cheng, J.; Singhal, S. S.; Saini, M. K.; Pandya, U.; Pikula, S.; Bandorowicz-Pikula, J.; Singh, S. V.; Zimniak, P.; Awasthi, Y. C. Novel Function of Human RLIP76: ATP-Dependent Transport of Glutathione Conjugates and Doxorubicin. Biochemistry 2000, 39, 9327-9334.
127. Awasthi, S.; Cheng, J. Z.; Singhal, S. S.; Pandya, U.; Sharma, R.; Singh, S. V.; Zimniak, P.; Awasthi, Y. C. Functional Reassembly of ATP-Dependent Xenobiotic Transport by the N- and C-Terminal Domains of RLIP76 and Identification of ATP Binding Sequences. Biochemistry 2001, 40, 4159-4168.
128. Singhal, S. S.; Singhal, J.; Cheng, J.; Pikula, S.; Sharma, R.; Zimniak, P.; Awasthi, Y. C.; Awasthi, S. Purification and Functional Reconstitution of Intact Ral-Binding GTPase Activating Protein, RLIP76, in Artificial Liposomes. Acta Biochim. Pol. 2001, 48, 551-562.
129. Pulaski, L.; Jedlitschky, G.; Leier, I.; Buchholz, U.; Keppler, D. Identification of the Multidrug-Resistance Protein (MRP) as the Glutathione-S-Conjugate Export Pump of Erythrocytes. Eur. J. Biochem. 1996, 241, 644-648.
130. Awasthi, S.; Singhal, S. S.; Singhal, J.; Virmani, A. K.; Zimniak, P.; Awasthi, Y. C. Anti-RLIP76 Antibodies Induce Apoptosis and Enhanced Doxorubicin Cytotoxicity in Lung Cancer Cells. Proceedings of the American Association of Cancer Research 2001, 42, Abst. 1507. *(Present as foot note)
131. Cheng, J. Z.; Sharma, R.; Yang, Y.; Singhal, S. S.; Sharma, A.; Saini, M. K.; Singh, S. V.; Zimniak, P.; Awasthi, S.; Awasthi, Y. C. Accelerated Metabolism and Exclusion of 4-Hydroxynonenal Through Induction of RLIP76 and Hgst5.8 is an Early Adaptive Response of Cells to Heat and Oxidative Stress J. Biol. Chem. 2001, 276, 41213-41223.
132. Saraste, M.; Sibbald, P. R.; Wittinghofer, A. The P-Loop - A Common Motif in ATP- and GTP-Binding Proteins. Trends. Biochem. Sci. 1990, 15, 430-434.
133. Langen, R.; Isas, J. M.; Hubbell, W. L.; Haigler, H. T. A Transmembrane form of Annexin Xii Detected by Site-Directed Spin Labeling. Proc. Natl. Acad. Sci. USA 1998, 95, 14060-14065.
134. Cartailler, J. P.; Haigler, H. T.; Luecke, H. Annexin XII E105K Crystal Structure: Identification of a pH-Dependent Switch for Mutant Hexamerization. Biochemistry 2000, 39, 2475-2483.
135. Zheng, B.; Ma, Y. C.; Ostrom, R. S.; Lavoie, C.; Gill, G. N.; Insel, P. A.; Huang, X. Y.; Farquhar, M. G. Rgs-Px1, a Gap for Galphas and Sorting Nexin in Vesicular Trafficking. Science 2001, 294, 1939-1942.
136. Moskalenko, S.; Henry, D. O.; Rosse, C.; Mirey, G.; Camonis, J. H.; White, M. A the Exocyst is a Ral Effector Complex. Nat. Cell. Biol. 2002, 4, 66-72.
137. Krishna, R.; Mayer, L. D. Multidrug Resistance (MDR) in Cancer. Mechanisms, Reversal Using Modulators of MDR and the Role of MDR Modulators in Influencing the Pharmacokinetics of Anticancer Drugs. Eur. J. Pharm. Sci. 2000, 11, 265-283.
138. Stein, W. D. Kinetics of the Multidrug Transporter (P-Glycoprotein) and its Reversal. Physiol. Rev. 1997, 77, 545-590.
139. Ibrahim, S.; Peggins, J.; Knapton, A.; Licht, T.; Aszalos, A. Influence of Antipsychotic, Antiemetic, and Ca (2+) Channel Blocker Drugs on the Cellular Accumulation of the Anticancer Drug Daunorubicin: P-Glycoprotein Modulation. J. Pharmacol. Exp. Ther. 2000, 5, 1276-1283.
140. Hollt, V.; Kouba, M.; Dietel, M.; Vogt, G. Stereoisomers of Calcium Antagonists which Differ Markedly in their Potencies as Calcium Blockers are Equally Effective in Modulating Drug Transport by P-Glycoprotein. Biochem. Pharmacol. 1992, 43, 2601-2608.
141. Ganapathi, R.; Grabowski, D.; Turinic, R.; Valenzuela, R. Correlation Between Potency of Calmodulin Inhibitors and Effects on Cellular Levels and Cytotoxic Activity of Doxorubicin (Adriamycin) in Resistant P388 Mouse Leukemia Cells. Eur. J. Cancer Clin. Oncol. 1984, 20, 799-806.
142. Teodori, E.; Dei, S.; Quidu, P.; Budriesi, R.; Chiarini, A.; Garnier-Suillerot, A.; Gualtieri, F.; Manetti, D.; Romanelli, M. N.; Scapecchi, S. Design, Synthesis, and In Vitro Activity of Catamphiphilic Reverters of Multidrug Resistance: Discovery of a Selective, Highly Efficacious Chemosensitizer with Potency in the Nanomolar Range. J. Med. Chem. 1999, 42, 1687-1697.
143. Lovekamp, T.; Cooper, P.S.; Hardison, J.; Bryant, S.D.; Guerrini, R.; Balboni, G.; Salvadori, S.; Lazarus, L.H. Inhibition of Human Multidrug Resistance P-Glycoprotein 1 by Analogues of a Potent Delta-Opioid Antagonist. Brain Res. 2001, 902, 131-134.
144. Wigler, P. W. Psc833, Cyclosporin A, and Dexniguldipine Effects on Cellular Calcein Retention and Inhibition of the Multidrug Resistance Pump in Human Leukemic Lymphoblasts. Biochem. Biophys. Res. Commun. 1999, 257, 410-413.
145. Gekeler, V.; Ise, W.; Sanders, K. H.; Ulrich, W. R.; Beck, J. the Leukotriene Ltd4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance. Biochem. Biophys. Res. Commun. 1995, 208, 345-352.
146. Sumizawa, T.; Chen, Z. S.; Chuman, Y.; Seto, K.; Furukawa, T.; Haraguchi, M.; Tani, A.; Shudo, N.; Akiyama, S. I. Reversal of Multidrug Resistance-Associated Protein-Mediated Drug Resistance by the Pyridine Analog Pak-104p. Mol. Pharmacol. 1997, 51, 399-405.
147. Marbeuf-Gueye, C.; Salerno, M.; Quidu, P.; Garnier- Suillerot, A. Inhibition of the P-Glycoprotein- and Multidrug Resistance Protein-Mediated Efflux of Anthracyclines and Calceinacetoxymethyl Ester by Pak-1049. Eur. J. Pharmacol. 2000, 391, 207-216.
148. Kokubu, N.; Cohen, D.; Watanabe, T. Functional Modulation of ATPase of P-Glycoprotein by C219, a Monoclonal Antibody Against P-Glycoprotein. Biochem. Biophys. Res. Commun. 1997, 230, 398-401.
149. Hipfner, D. R.; Mao, Q.; Qiu, W.; Leslie, E. M.; Gao, M.; Deeley, R. G.; Cole, S. P. Monoclonal Antibodies that Inhibit the Transport Function of the 190-kDa Multidrug Resistance Protein, MRP. Localization of their Epitopes to the Nucleotide-Binding Domains of the Protein. J. Biol. Chem. 1999, 274, 15420-15426.
150. Lum, B. L.; Gosland, M. P. MDR Expression in Normal Tissues. Pharmacologic Implications for the Clinical Use of P-Glycoprotein Inhibitors. Hematol. Oncol. Clin. North. Am. 1995, 9, 319-336.
151. Tsimberidou, A. M.; Paterakis, G.; androutsos, G.; Anagnostopoulos, N.; Galanopoulos, A.; Kalmantis, T.; Meletis, J. Rombos, Y.; Sagriotis, A.; Symeonidis, A.; Tiniakou, M.; Zoumbos, N.; Yataganas, X. Evaluation of the Clinical Relevance of the Expression and Function of P-Glycoprotein, Multidrug Resistance Protein and Lung Resistance Protein in Patients with Primary Acute Myelogenous Leukemia. Leuk. Res. 2002, 26, 143-154.
152. Homicek, F. J.; Gebhardt, M. C.; Wolfe, M. W.; Kharrazi, F. D.; Takeshita, H.; Parekh, S. G.; Zurakowski, D.; Mankin, H. J. P-Glycoprotein Levels Predict Poor Outcome in Patients with Osteosarcoma. Clin. Orthop. 2000, 373, 11-17.
153. Consoli, U.; Santonocito, A.; Stagno, F.; Fiumara, P.; Privitera, A.; Parisi, G.; Giustolisi, G. M.; Pavone, B.; Palumbo, G. A.; Di Raimondo, F.; Milone, G.; Guglielmo, P.; Giustolisi, R. Multidrug Resistance Mechanisms in Chronic Lymphocytic Leukaemia. Br. J. Haematol. 2002, 116, 774-780.
154. Ohno, N.; Tani, A.; Uozumi, K.; Hanada, S.; Furukawa, T.; Akiba, S.; Sumizawa, T, Utsunomiya, A.; Arima, T.; Akiyama, S. Expression of Functional Lung Resistance-Related Protein Predicts Poor Outcome in Adult T-Cell Leukemia. Blood 2001, 98, 1160-1165.
155. Damiani, D.; Michelutti, A.; Michieli, M.; Masolini, P.; Stocchi, R.; Geromin, A.; Ermacora, A.; Russo, D.; Fanin, R.; Baccarani, M. P-Glycoprotein, Lung Resistance-Related Protein and Multidrug Resistance-Associated Protein in De Novo Adult Acute Lymphoblastic Leukaemia. Br. J. Haematol. 2002, 116, 519-527.
156. Lowe, S. W.; Ruley, H. E.; Jacks, T.; Housman, D. E. p53-Dependent Apoptosis Modulates the Cytotoxicity of Anticancer Agents. Cell 1993, 74, 957-967.
157. Miyashita, T.; Krajewski, S.; Krajewska, M.; Wang, H. G.; Lin, H. K.; Liebermann, D. A.; Hoffman, B.; Reed, J. C. Tumor Suppressor p53 is a Regulator of Bcl-2 and Bax Gene Expression In Vitro and In Vivo. Oncogene 1994, 9, 1799-805.
158. Reed, J. C. Regulation of Apoptosis by Bcl-2 Family Proteins and its Role in Cancer and Chemoresistance. Curr. Opin. Oncol, 1995, 7, 541-546.